BioSig Technologies, Financials
| BSGM Stock | USD 0.49 0.06 10.91% |
With this module, you can analyze BioSig financials for your investing period. You should be able to track the changes in BioSig Technologies, individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
BioSig |
Understanding current and past BioSig Technologies, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioSig Technologies,'s financial statements are interrelated, with each one affecting the others. For example, an increase in BioSig Technologies,'s assets may result in an increase in income on the income statement.
The data published in BioSig Technologies,'s official financial statements typically reflect BioSig Technologies,'s business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving BioSig Technologies,'s quantitative information. For example, before you start analyzing numbers published by BioSig accountants, it's essential to understand BioSig Technologies,'s liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.
BioSig Technologies, Stock Summary
BioSig Technologies, competes with Neuropace, Inogen, SurModics, Pulmonx Corp, and Apyx Medical. BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.Specialization | Healthcare, Medical Devices |
| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US09073N2018 |
| CUSIP | 09073N201 09073N300 09073N102 |
| Location | Connecticut; U.S.A |
| Business Address | 55 Greens Farms |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.biosig.com |
| Phone | 203 409 5444 |
| Currency | USD - US Dollar |
BioSig Technologies, Key Financial Ratios
There are many critical financial ratios that BioSig Technologies,'s investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioSig Technologies, reports annually and quarterly.| Return On Equity | -59.77 | ||||
| Return On Asset | -4.48 | ||||
| Target Price | 6.0 | ||||
| Beta | 0.84 |
BioSig Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioSig Technologies,'s current stock value. Our valuation model uses many indicators to compare BioSig Technologies, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioSig Technologies, competition to find correlations between indicators driving BioSig Technologies,'s intrinsic value. More Info.BioSig Technologies, Common is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioSig Technologies,'s earnings, one of the primary drivers of an investment's value.BioSig Technologies, Systematic Risk
BioSig Technologies,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioSig Technologies, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on BioSig Technologies, correlated with the market. If Beta is less than 0 BioSig Technologies, generally moves in the opposite direction as compared to the market. If BioSig Technologies, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioSig Technologies, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioSig Technologies, is generally in the same direction as the market. If Beta > 1 BioSig Technologies, moves generally in the same direction as, but more than the movement of the benchmark.
BioSig Technologies, March 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioSig Technologies, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioSig Technologies, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioSig Technologies, Common based on widely used predictive technical indicators. In general, we focus on analyzing BioSig OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioSig Technologies,'s daily price indicators and compare them against related drivers.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 45.61 | |||
| Value At Risk | (17.91) | |||
| Potential Upside | 13.68 |
Other Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.